Skip to main content
Erschienen in: International Urology and Nephrology 2/2017

16.11.2016 | Urology - Original Paper

Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade

verfasst von: Yulian Mytsyk, Ihor Dutka, Yuriy Borys, Iryna Komnatska, Iryna Shatynska-Mytsyk, Ammad Ahmad Farooqi, Katarina Gazdikova, Martin Caprnda, Luis Rodrigo, Peter Kruzliak

Erschienen in: International Urology and Nephrology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Renal cell carcinoma (RCC) represents the most common malignant epithelial neoplasm of the kidney. Accurate assessment of the renal masses, defining the histologic subtype and the grade of differentiation of the tumor, is vital to ensure an adequate case management as well as for staging and prognosis. Recently, diffusion-weighted imaging (DWI) magnetic resonance imaging (MRI) tends to be increasingly appealing for the clinicians as an imaging procedure of choice for the diagnosis and staging of the RCC, which is predetermined by several advantages over CT. The goal of the survey was to assess the applicability of the apparent diffusion coefficient (ADC) of the DWI MRI for the differential diagnostics, histologic subtyping, and defining the grade of differentiation of the RCC.

Methods

The study enrolled 288 adult patients with renal lesions: 188 patients with solid RCC—126 patients with clear cell subtype (ccRCC), 32 patients with papillary RCC (pRCC), 30 patients with chromophobe RCC (chRCC); 27 patient with cystic form or RCC (Bosniak cyst, category IV); 32 patients with renal angiomyolipoma (AML); 25 patients with renal oncocytoma (OC); and 16 patients with the renal abscess (AB). In total, 245 lesions were pathologically verified. As a reference, 19 healthy volunteers were included into the study. All patients underwent MRI of the kidneys, involving DWI with subsequent evaluation of the ADC.

Results

There was a reliable difference (p < 0.05) in mean ADC values between the normal renal parenchyma (NRP), solid RCC of different histologic subtypes and grades, cystic RCC, and benign renal lesions. The mean ADC values obtained in the result of the study were (×10−3 mm2/s): 2.47 ± 0.12 in NRP, 1.63 ± 0.29 in all solid RCCs, 1.82 ± 0.22 in solid ccRCC (1.92 ± 0.11—Fuhrman grade I, 1.84 ± 0.14—Fuhrman grade II, 1.79 ± 0.10—Fuhrman grade III, 1.72 ± 0.06—Fuhrman grade IV), 1.61 ± 0.07 in pRCC, 1.46 ± 0.09 in chRCC, 2.68 ± 0.11 in cystic RCC, 2.13 ± 0.08 in AML, 2.26 ± 0.06 in OC, and 3.30 ± 0.07 in AB.

Conclusion

The data received in our study demonstrate a substantial restriction of diffusion of hydrogen molecules in tissues of ccRCC in comparison with the healthy renal parenchyma preconditioned by the greater density of tumor. A statistically significant difference in mean ADC values of ccRCC with different grades of nuclear pleomorphism by Fuhrman was observed: Low-grade tumors showed higher mean ADC values compared to high-grade tumors. The modality of the MRI DWI along with ADC measurement allows to reliably differentiate between the solid RCC of main histologic subtypes and grades, cystic RCC, and the benign renal lesions.
Literatur
1.
Zurück zum Zitat Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249CrossRefPubMed Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249CrossRefPubMed
2.
Zurück zum Zitat Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27:612–624CrossRefPubMed Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27:612–624CrossRefPubMed
3.
Zurück zum Zitat Miguel V, Fernando L, Carlos M et al (2009) Nuclear grade prediction of renal cell carcinoma using contrasted computed tomography. J Urol 181:249 Miguel V, Fernando L, Carlos M et al (2009) Nuclear grade prediction of renal cell carcinoma using contrasted computed tomography. J Urol 181:249
4.
Zurück zum Zitat Kim JK, Kim TK, Ahn HJ, Kim CS, Kim KR, Cho KS (2002) Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol 178:1499–1506CrossRefPubMed Kim JK, Kim TK, Ahn HJ, Kim CS, Kim KR, Cho KS (2002) Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol 178:1499–1506CrossRefPubMed
5.
Zurück zum Zitat Sheir KZ, El-Azab M, Mosbah A, El-Baz M, Shaaban AA (2005) Differentiation of renal cell carcinoma subtypes by multislice computerized tomography. J Urol 174:451–455CrossRefPubMed Sheir KZ, El-Azab M, Mosbah A, El-Baz M, Shaaban AA (2005) Differentiation of renal cell carcinoma subtypes by multislice computerized tomography. J Urol 174:451–455CrossRefPubMed
6.
Zurück zum Zitat Moinzadeh A, Gill IS, Finelli A, Kaouk J, Desai M (2006) Laparoscopic partial nephrectomy: 3-year followup. J Urol 175:459–462CrossRefPubMed Moinzadeh A, Gill IS, Finelli A, Kaouk J, Desai M (2006) Laparoscopic partial nephrectomy: 3-year followup. J Urol 175:459–462CrossRefPubMed
7.
Zurück zum Zitat Le Bihan D (1991) Molecular diffusion nuclear magnetic resonance imaging. Magn Reson 7:1–30 Le Bihan D (1991) Molecular diffusion nuclear magnetic resonance imaging. Magn Reson 7:1–30
8.
Zurück zum Zitat Pedrosa I, Sun MR, Spencer M, Genega EM, Olumi AF, Dewolf WC, Rofsky NM (2008) MR imaging of renal masses: correlation with findings at surgery and pathologic analysis. Radiographics 28:985–1003CrossRefPubMed Pedrosa I, Sun MR, Spencer M, Genega EM, Olumi AF, Dewolf WC, Rofsky NM (2008) MR imaging of renal masses: correlation with findings at surgery and pathologic analysis. Radiographics 28:985–1003CrossRefPubMed
9.
Zurück zum Zitat Taouli B, Thakur RK, Mannelli L, Babb JS, Kim S, Hecht EM, Lee VS, Israel GM (2009) Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology 251:398–407CrossRefPubMed Taouli B, Thakur RK, Mannelli L, Babb JS, Kim S, Hecht EM, Lee VS, Israel GM (2009) Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology 251:398–407CrossRefPubMed
10.
Zurück zum Zitat Sandrasegaran K, Sundaram CP, Ramaswamy R, Akisik FM, Rydberg MP, Lin C, Aisen AM (2010) Usefulness of diffusion-weighted imaging in the evaluation of renal masses. AJR Am J Roentgenol 194:438–445CrossRefPubMed Sandrasegaran K, Sundaram CP, Ramaswamy R, Akisik FM, Rydberg MP, Lin C, Aisen AM (2010) Usefulness of diffusion-weighted imaging in the evaluation of renal masses. AJR Am J Roentgenol 194:438–445CrossRefPubMed
12.
Zurück zum Zitat McDonald RJ, McDonald JS, Bida JP, Carter RE, Fleming CJ, Misra S, Williamson EE, Kallmes DF (2016) Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? Radiology 278:306CrossRefPubMed McDonald RJ, McDonald JS, Bida JP, Carter RE, Fleming CJ, Misra S, Williamson EE, Kallmes DF (2016) Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? Radiology 278:306CrossRefPubMed
13.
Zurück zum Zitat Wang H, Cheng L, Zhang X, Wang D, Guo A, Gao Y, Ye H (2010) Renal cell carcinoma: diffusion-weighted mr imaging for subtype differentiation at 3.0 T. Radiology 257:135–143CrossRefPubMed Wang H, Cheng L, Zhang X, Wang D, Guo A, Gao Y, Ye H (2010) Renal cell carcinoma: diffusion-weighted mr imaging for subtype differentiation at 3.0 T. Radiology 257:135–143CrossRefPubMed
14.
Zurück zum Zitat Razek AA, Farouk A, Mousa A, Nabil N (2011) Role of diffusion-weighted magnetic resonance imaging in characterization of renal tumors. J Comput Assist Tomogr 35:332–336CrossRefPubMed Razek AA, Farouk A, Mousa A, Nabil N (2011) Role of diffusion-weighted magnetic resonance imaging in characterization of renal tumors. J Comput Assist Tomogr 35:332–336CrossRefPubMed
15.
Zurück zum Zitat Sun M, Lughezzani G, Jeldres C, Isbarn H, Shariat SF, Arjane P, Widmer H, Pharand D, Latour M, Perrotte P, Patard JJ, Karakiewicz PI (2009) A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma. Eur Urol 56:775–781CrossRefPubMed Sun M, Lughezzani G, Jeldres C, Isbarn H, Shariat SF, Arjane P, Widmer H, Pharand D, Latour M, Perrotte P, Patard JJ, Karakiewicz PI (2009) A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma. Eur Urol 56:775–781CrossRefPubMed
16.
Zurück zum Zitat Hong SK, Jeong CW, Park JH, Kim HS, Kwak C, Choe G, Kim HH, Lee SE (2011) Application of simplified Fuhrman grading system in clear-cell renal cell carcinoma. BJU Int 107:409–415CrossRefPubMed Hong SK, Jeong CW, Park JH, Kim HS, Kwak C, Choe G, Kim HH, Lee SE (2011) Application of simplified Fuhrman grading system in clear-cell renal cell carcinoma. BJU Int 107:409–415CrossRefPubMed
17.
Zurück zum Zitat Rosenkrantz AB, Niver BE, Fitzgerald EF, Babb JS, Chandarana H, Melamed J (2010) Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. AJR Am J Roentgenol 195:W344–W351CrossRefPubMed Rosenkrantz AB, Niver BE, Fitzgerald EF, Babb JS, Chandarana H, Melamed J (2010) Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. AJR Am J Roentgenol 195:W344–W351CrossRefPubMed
18.
Zurück zum Zitat Mytsyk Y, Borys Y, Komnatska I, Dutka I, Shatynska-Mytsyk I (2014) Value of the diffusion-weighted MRI in the differential diagnostics of malignant and benign kidney neoplasms—our clinical experience. Pol J Radiol 79:290–295CrossRefPubMedPubMedCentral Mytsyk Y, Borys Y, Komnatska I, Dutka I, Shatynska-Mytsyk I (2014) Value of the diffusion-weighted MRI in the differential diagnostics of malignant and benign kidney neoplasms—our clinical experience. Pol J Radiol 79:290–295CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Lassel EA, Rao R, Schwenke C, Schoenberg SO, Michaely HJ (2014) Diffusion-weighted imaging of focal renal lesions: a meta-analysis. Eur Radiol 24:241–249CrossRefPubMed Lassel EA, Rao R, Schwenke C, Schoenberg SO, Michaely HJ (2014) Diffusion-weighted imaging of focal renal lesions: a meta-analysis. Eur Radiol 24:241–249CrossRefPubMed
20.
Zurück zum Zitat Zhang H, Gan Q, Wu Y, Liu R, Liu X, Huang Z, Yuan F, Kuang M, Song B (2016) Diagnostic performance of diffusion-weighted magnetic resonance imaging in differentiating human renal lesions (benignity or malignancy): a meta-analysis. Abdom Radiol (NY) 41:1997–2010CrossRef Zhang H, Gan Q, Wu Y, Liu R, Liu X, Huang Z, Yuan F, Kuang M, Song B (2016) Diagnostic performance of diffusion-weighted magnetic resonance imaging in differentiating human renal lesions (benignity or malignancy): a meta-analysis. Abdom Radiol (NY) 41:1997–2010CrossRef
Metadaten
Titel
Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade
verfasst von
Yulian Mytsyk
Ihor Dutka
Yuriy Borys
Iryna Komnatska
Iryna Shatynska-Mytsyk
Ammad Ahmad Farooqi
Katarina Gazdikova
Martin Caprnda
Luis Rodrigo
Peter Kruzliak
Publikationsdatum
16.11.2016
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 2/2017
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1460-3

Weitere Artikel der Ausgabe 2/2017

International Urology and Nephrology 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.